It is axiomatic amongst neurophysiologists that the functional unit of the nervous system is the neurone and that the properties of the nervous system derive from the anatomical arrangement and the physiological strength of the synaptic connexions between neurones. General anaesthetics are drugs that disrupt certain aspects of the function of the nervous system such as consciousness and the appreciation of pain, whilst preserving others such as respiration. So, without prejudice to the discussion about the possible sites of action of general anaesthetics within the CNS in general and the brain in particular, it is logical to conclude that they must ultimately produce their characteristic effects by disrupting some aspects of the communication between neurones. Since the primary route of communication between neurones is the synapse, the actions of general anaesthetics on synaptic transmission may be considered the cellular basis of anaesthetic action. This view has been held by many neurophysiologists since Sowton and Sherrington (1905) showed that the concentration of chloroform required to block a reflex motor response was far smaller than that required to block the motor response elicited by direct electrical stimulation of the motor nerve. The vulnerability of synaptic transmission to general anaesthetics was subsequently confirmed by Larrabee and Posternak (1952) who used sympathetic ganglia to show that many anaesthetic substances blocked transmission across the synapse without apparently disrupting nerve impulse conduction in the afferent axons. This, however, was not true of all agents, as the short chain n-alkanols and urethane exhibited no such selectivity. Nevertheless, this work served to reinforce the view that general anaesthetics act by disrupting synaptic transmission.
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showed that excitatory synaptic transmission in sympathetic ganglia was reduced by a variety of general anaesthetics including chloroform, ether and pentobarbitone, but it was not until Somjen and Gill (1963) and Somjen (1963) showed that ether and barbiturates depressed the excitatory postsynaptic potentials (EPSP) of motorneurones that clear evidence of a direct action of anaesthetics on central synaptic transmission was obtained. Subsequently, it was shown that halothane and barbiturates also depress excitatory synaptic transmission in the cuneate nucleus (Galindo, 1969) . Within the brain itself a wide range of anaesthetics have now been found to depress excitatory synaptic transmission in the hippocampal formation (Richards and White, 1975) and olfactory cortex (Richards, 1972 (Richards, , 1973 Richards and Hesketh, 1975; Richards, Russell and Smaje, 1975) . In all of these studies the depression of excitatory synaptic transmission could be demonstrated with concentrations of anaesthetic comparable to those required for general anaesthesia. Angel and Unwin (1970) have shown that urethane blocks synaptic transmission in the ventrobasal thalamus. However, Nicoll (1972) has shown that the unusual dendro-dendritic excitatory synapses of the olfactory bulb are relatively resistant to the depressent actions of general anaesthetics. There is no clear evidence, at present, of any general anaesthetic actually increasing the efficacy of excitatory synapses.
The actions of anaesthetics on inhibitory synaptic transmission are more complex than those on excitatory synaptic transmission. Eccles, Schmidt and Willis (1963) reported that presynaptic inhibition was enhanced by barbiturates and chloralose but depressed by ether, paraldehyde, urethane and chloral hydrate. Larson and Major (1970) reported that hexobarbitone increased the duration of inhibitory postsynaptic potentials in the spinal cord and Nicoll later showed that other anaesthetics increased the duration of postsynaptic inhibition in © The Macmillan Press Ltd 1983 the olfactory bulb (Nicoll, 1972) and hippocampus (Nicoll et al., 1975) . These observations are important because they suggest that anaesthetics may depress the transmission of information in the CNS in a variety of ways: by blocking the transmission of afferent signals from the periphery to the brain as a result of presynaptic inhibition, by reducing the flow of information through the relays of the CNS as a result of a decrease in excitatory synaptic transmission and by an increase in the strength of inhibitory synaptic transmission at certain synapses. However, anaesthetics do not augment all forms of inhibitory synaptic transmission. Weakly, Esplin and Zablocka (1968) were unable to detect a specific increase in the direct inhibition of motoneurones after administration of barbiturates and Frank and Ohta (1971) found that the reticulo-spinal inhibitory pathway was readily blocked by pentobarbitone, an observation which caused them to speculate that this block might be responsible for the excitatory effects often seen during the induction of anaesthesia.
Having established that anaesthetics modify the synaptic processes of the CNS, the next step in the analysis of their action is to determine the mechanisms by which they alter synaptic function. To do this we may broadly divide synaptic transmission into four processes:
(i) impulse conduction in the afferent axons, (ii) the release of transmitter into the synaptic cleft, (iii) the binding of released transmitter to specific receptors on the postsynaptic membrane, (iv) a change in the conductance of the postsynaptic membrane leading to excitation or inhibition of the postsynaptic neurone. In addition to these processes, it is possible that anaesthetics may affect the excitability of neurones by a direct action on their membrane potential or electrical threshold. Each of these possibilities will now be considered in turn.
Actions on impulse conduction
The early work of Sowton and Sherrington (1905) and the more recent observations of Larrabee and Posternak (1952) and of Richards (1972 Richards ( ,1973 have all agreed that synaptic transmission is depressed by concentrations of anaesthetics that are not sufficient to block the conduction of impulses in axons. These observations are the basis of the argument that general anaesthetics have a selective depressant action on the actual process of chemical transmissionIn fact the selectivity is not very great. Larrabee and Posternak showed that impulse conduction could be blocked by concentrations of pentobarbitone only five to 10 times that required to block synaptic transmission. Since the susceptibility of nerves to anaesthestic action varies inversely with their diameter (see for example Nathan and Sears, 1961) and since axons branch extensively as they form their synaptic connexions, each successive branch being of smaller diameter than its predecessor, it has been strongly argued that the susceptibility of synapses to the action of anaesthetics reflects a lower safety factor for impulse conduction in the terminal branches of the afferent axons (Seeman, 1972; Staiman and Seeman, 1974) . Furthermore, local anaesthetics can be used to produce a degree of general anaesthesia (Frank and Sanders, 1963) . Therefore, it has been argued, general anaesthetics act like local anaesthetics on the terminal branches of axons to depress synaptic transmission. The great attraction of this idea is that it invokes a single mechanism to account for the actions of both local and general anaesthetics.
That general anaesthetics such as halothane or pentobarbitone can affect impulse conduction in the afferent axons is not in doubt. The crucial question is whether they do so at the concentrations required for general anaesthesia. All the early work suggested that impulse conductions in axons was resistant to the concentrations of anaesthetics ordinarily required for surgical anaesthesia. More recent observations with a variety of anaesthetics in the olfactory cortex (Richards 1972 (Richards , 1973 Richards, Russell and Smaje, 1975) and the hippocampus (Richards and White, 1975) showed that excitatory synaptic transmission was depressed with no change in the conduction of impulses by small axons and with no significant change in the latency of the synaptic potential. Furthermore, it is difficult to envisage such a mechanism permitting the enhancement of inhibitory synaptic transmission. There is no reason to suppose that the properties of those axons releasing an inhibitory transmitter are radically different from those releasing an excitatory one.
The final, and most direct, evidence against this idea has come from a close comparison of the actions of tetrodotoxin and pentobarbitone on synaptic transmission in in vitro preparations of the olfactory cortex (Richards, 1982) . In this preparation it was found that pentobarbitone 0.3 mmol litre" 1 and tetrodotoxin 2 x 10~8mol litre" 1 blocked synaptic transmission by a similar amount. However, when pentobarbitone was applied, the depression of the synaptic potentials occurred without any change in the latency or amplitude of the action potentials of the afferent fibres. In contrast, when tetrodotoxin was applied, the depression of the synaptic potentials was paralleled by a decrease in the amplitude of the presynaptic action potential and an increase in its latency. Now, tetrodotoxin acts by blocking the sodium channel of nerve fibres and has no action on synaptic channels (Kao, 1966) and so it may be regarded as having a purely local anaesthetic action. In contrast pentobarbitone is a very effective general anaesthetic. The fact that the two drugs have such radically different modes of action rules out the idea that general and local anaesthetics both act by blocking impulse conduction.
Anaesthetic actions on transmitter release
If the effects of anaesthetics on the efficacy of chemical transmission are to be attributed to effects on Transmitter release from nerve terminals, two effects must be sought-a decrease in transmitter release from excitatory synapses and an increase in transmitter release from inhibitory synapses. There is, however, a major technical problem-the transmitter substances acting at specific central synapses remain largely unknown and the heterogeneity of the synaptic connexions in the brain adds to the difficulties. As a result it has been necessary to rely on either neurochemical experiments with putative transmitter substances that are unsupported by the requisite physiological studies or physiological studies unsupported by the appropriate neurochemical experiments.
The most convincing evidence that anaesthetics can decrease the amount of transmitter released by nerve impulses has been provided by studies on the release of acetylcholine from sympathetic ganglia (Matthews and Quilliam, 1964) . This work showed that a number of central depressants, including amylobarbitone, depressed the amount of acetylcholine released by electrical stimulation of the preganglionic nerves. Within the CNS itself studies have centred on the excitatory amino acids Lglutamate and L-aspartate and the inhibitory amino acid y-amino butyric acid (GABA). Studies using in vitro preparations of the olfactory cortex have revealed that small concentrations of pentobarbitone depress the amount of aspartate and glutamate released by electrical stimulation of the lateral olfactory tract whilst slightly enhancing the amount of GABA released (Collins, 1980) . This curious dichotomy of effect has been seen with barbiturates in other preparations (Potashner et al., 1980; Minchin, 1981; Kendall and Minchin, 1982) and provides a neurochemical basis for the differential effects of the barbiturates on excitatory and inhibitory synaptic transmission. Other anaesthetics, however, did not alter the amount of GABA or aspartate released from slices of thalamus in response to depolarization of the tissue by solutions containing protoveratrine or K + 50 mmol litre" 1 (Kendall and Minchin, 1982) .
Electrophysiological evidence that pentobarbitone and thiopentone cause a reduction in the release of transmitters from central synapses comes from the elegant study of Weakly (1969) who found that small concentrations of these anaesthetics decreased the quantal content of EPSP of triceps surae motorneurones, but that the miniature EPSP were unchanged in amplitude. As these results were obtained with single fibre activation of the motorneurones they strongly suggest that small concentrations of these two barbiturates depress excitatory synaptic transmission by reducing the output of transmitter from the presynaptic nerve terminals.
If we accept that anaesthetics change the pattern of release of putative transmitters, and that these changes reflect genuine changes in the release of transmitters by nerve terminals, the underlying mechanisms remain to be established. It is unlikely that decreases in transmitter release can be attributed to alterations in the concentrations of amino acids and other transmitters in the brain as these remain either constant (for example glutamate, aspartate and GABA (Potashner et al., 1980) ) or are increased (for example acetylcholine (Crossland and Merrick, 1954) ). The physiological evidence is also consistent with the view that anaesthetics do not interfere with the synthesis and storage of transmitters in the presynaptic terminals, as post-tetanic potentiation and frequency potentiation can readily be observed in preparations of the CNS exposed to anaesthetics (Somjen, 1963; Richards 1972 Richards , 1973 Richards and White, 1975) . Such observations are not consistent with the view that anaesthetics interfere with the mobilization of transmitter for release.
For the present we must conclude that the alterations in transmitter release caused by anaesthetics are caused by direct actions on the neurosecretory process itself. A full explanation of the differential actions of the barbiturates on the release of excitatory and inhibitory synaptic transmitters remains to be worked out.
The action of anaesthetics on postsynaptic receptors
Whilst there is now good evidence to suggest that anaesthetics can modulate the release of transmitters from nerve terminals, it is possible that the postsynaptic receptors may also be affected by anaesthetics. However, as with current attempts to study the actions of anaesthetics on the release of neurotransmitters, our attempts to study their actions on the sensitivity of the postsynaptic membrane to neurotransmitters are necessarily limited by the fact that we do not know with any certainty which substances are acting as transmitters at specific synapses. Consequently, virtually all the studies that have so far been attempted have examined the effects of anaesthetics on the chemical sensitivity of neurones whose precise synaptic physiology is unknown. Our problems are compounded by the fact that it is not yet possible to separate the observed effects into those actions reflecting a disturbance of transmitter-receptor interactions and those reflecting disturbance of the subsequent changes in ionic permeability.
Despite these reservations, it has been possible to gain some insight into the way anaesthetics affect transmitter-receptor interactions by tvgamining the effect of anaesthetics on the sensitivity of the postsynaptic membrane to the putative amino acid transmitters. Such experiments exploit the fact that these amino acids, like many other drugs, are charged and can be released in a controlled manner from microelectrodes by applying a d.c. voltage of appropriate sign between an electrode in the micropipette and a ground electrode connected to the biological preparation under study. This technique is called iontophoresis or ionophoresis.
Neurones in the mammalian brain have been shown to be very sensitive to ionophoretically applied L-aspartate and L-glutamate (Curtis, Phillis and Watkins, 1960) and it has been widely believed that these amino acids are major excitatory transmitters. Indeed, in two areas, the hippocampus and olfactory cortex, the release of glutamate and aspartate has been associated with synaptic activity (Bradford and Richards, 1976; Collins, 1979; Cotman and Nadler, 1981) . Crawford and Curtis (1966) showed that barbiturates reduced the sensitivity of neurones in the cerebral cortex to glutamate. Later Galindo (1969) confirmed this in a study of neurones in the cuneate nucleus. However, halothane did not affect the sensitivity of glutamate (see also Crawford, 1970) . More recently Richards and Smaje (1976) found that a number of anaesthetics including ether, methohexitone and pentobarbitone depressed the sensitivity of cells in the olfactory cortex to glutamate. These results offer an explanation of the mechanism by which some anaesthetics depress excitatory synaptic transmission in the olfactory cortex. In agreement with Galindo's (1969) results, Richards and Smaje found that halothane did not depress the sensitivity of neurones in the olfactory cortex to glutamate, so this anaesthetic presumably works by depressing the release of transmitter from presynaptic terminals. A similar conclusion has been reached by Zorychta, Esplin and Capek(1975) for the action of halothane on the spinal cord.
It is now widely accepted that the major inhibitory synaptic transmitter in the brain is GABA. Nicoll (1975) has shown that pentobarbitone increases the effects of GABA on frog motorneurones. Ransom and Barker (1976) found that pentobarbitone enhances the hyperpolarizing action of GABA, but not of glycine, on mouse spinal neurones grown in tissue culture. These results provide a possible explanation of the increase in inhibition that is caused by barbiturates and by some other anaesthetics. This increase in the effect of GABA is apparently not the result of a decrease in the uptake of GABA by pentobarbitone or a result of an increase in the affinity of the receptor for GABA Qessell and Richards, 1977; Minchin, 1981) , but reflects an increase in the time for which the ionic channels remain open (Barker and Ransom, 1980) . Acetylcholine receptors in the brain are predominantly muscarinic (Krnjevic, 1974) and do not produce the short latency, brief responses characteristic of rapidly transmitting synapses found throughout the CNS in general and the sensory pathways in particular. Nevertheless, in sympathetic ganglia, muscarinic acetylcholine receptors are thought to mediate slow synaptic excitation and inhibition in certain types of neurone (Weight, 1974) and may well do so in the brain. Several anaesthetics have been reported to abolish muscarinic excitation of cortical neurones (Catchlove, Krnjevic and Maretic, 1972) , but since these experiments have been carried out in vivo the observed effects may reflect a generalized depression of neuronal activity as a result of anaesthetic action on the brain as a whole rather than a specific interaction between anaesthetic and receptor. More recent studies by Smaje (1976) showed that volatile anaesthetics such as halothane and methoxyflurane enhanced the response to ionophoretically applied acetylcholine, while alphaxalone depressed it. Pentobarbitone had no consistent effect. Similar results were found with preparations in which synaptic transmission had been blocked by manipulating the ionic composition of the bathing medium. We may, therefore, conclude that these results reflect the effects of anaesthetics directly on postsynaptic muscarinic receptors.
Anaesthetic action on the postsynaptic membrane
In addition to their known actions on the processes involved in chemical transmission, anaesthetics could decrease the electrical excitability of neurones by a direct action on non-synaptic regions of the postsynaptic membrane. Thus anaesthetics could increase the threshold depolarization required for action potential generation or they could decrease the passive spread (that is, electrotonic conduction) of excitatory synaptic potentials from the dendrites to the axon hillock by increasing the resting conductance of the membrane. Somjen and Gill (1963) were the first to address these questions and found that ether and thiopentone increased the threshold of some, but not all motomeurones. In other motorneurones the threshold was actually decreased. These results were obtained by intracellular recording from motorneurones of spinal cats given large doses of thiopentone (30mgkg"') or unspecified concentrations of ether. A later study by Weakly (1969) found that smaller doses (5-lOmgkg" 1 ) of thiopentone or pentobarbitone had no effect qn the electrical threshold or membrane conductance of motorneurones. Using field potential analysis Richards (1972 Richards ( , 1973 was unable to find any evidence that pentobarbitone or halothane altered the electrical properties of neurones in the olfactory cortex. A similar lack of effect was found with volatile anaesthetics in the hippocampus (Richards and White, 1975) .
More recent studies have shown that barbiturates may cause an increase in the resting membrane conductance of some neurones (Nicoll, 1975; Scholfield, 1978) . Intriguingly, Huang and Barker (1980) have found that the (+)stereoisomer of pentobarbitone had a direct excitatory action on a small population of cultured spinal neurones while the ( -)isomer hyperpolarized (and so inhibited) the same cells.
These more recent observations indicate that, while general anaesthetics may not alter the electrical characteristics of the majority of cells, they may do so in some populations. That this alteration could be a significant factor in determining the character of the subsequent anaesthesia was shown by Huang and Barker (1980) .
CONCLUSIONS
The work that has just been briefly reviewed shows that there is no effect of anaesthetics on synaptic transmission that is common to all synapses and all anaesthetics. Thus local anaesthetics such as procaine affect synaptic transmission partly by reducing the efficiency of impulse conduction in the afferent axons while the commonly used general anaesthetics do not. Some anaesthetics reduce the release of transmitter from nerve terminals, but low concentrations of barbiturates increase the release; urethane and ketamine are without effect. The effects of anaesthetics on postsynaptic receptors are many and varied. This complexity has profound implications for theories of anaesthesia: the search for a unitary theory of anaesthesia is not furthered by a study of anaesthetic action on synaptic transmission. It is, of course, possible that there is a particular group of synapses somewhere in the brain whose function is essential to the maintenance of consciousness and on which all anaesthetics have a similar action. However, there is at present no evidence for such a population. It is more realistic to abandon a unitary theory of anaesthetic action and postulate that the effects of an anaesthetic at a particular site depend upon the precise structures of both anaesthetic and binding site. Detailed analysis shows that this idea can provide a framework for understanding the actions of anaesthetics on many systems (Richards 1978; 1980) , but it cannot by its very nature specify the precise lesions that are required to produce general anaesthesia. It implicitly assumes that there may be as many mechanisms as there are anaesthetics.
SUMMARY
This article reviews the actions of general anaesthetics on synapses in the mammalian central nervous system. It is shown that during general anaesthesia, anaesthetics act primarily on the chemical transmission process itself and do not affect the conduction of impulses in nerve axons or change the electrical excitability of neurones. Virtually all general anaesthetics depress excitatory synaptic transmission at concentrations required for surgical anaesthesia but some, notably the barbiturates, also increase the intensity of inhibitory synaptic transmission. Detailed analysis has found that small concentrations of barbiturates increase the amount of inhibitory transmitter released but decrease the amount of excitatory transmitter released. In addition to these effects on the neurosecretory process, anaesthetics directly affect the sensitivity of the postsynaptic receptors to transmitter substances, although the effects vary between anaesthetics and receptors. It is concluded that general anaesthesia results from a summation of a number of effects which together tend to depress the excitability of the CNS as a whole.
